Elevance Health, Inc. (ELV) stock
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 14/3010% below fair value
$433.93−12.35 (-2.77%)
Close on Nov 17, 2026Market cap $93.75BP/E 18.5Yield –
Elevance Health r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Elevance Health
Elevance Health has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?